FBLN7

Fibulin 7

Gene Information Card

Symbol FBLN7
Full Name fibulin 7
Gene Type protein-coding
Chromosomal Location 2q13
NCBI Gene ID 129804 ncbi.nlm.nih.gov/gene/129804
Ensembl ID ENSG00000144136
UniProt ID Q53RD9
OMIM ID 611082
HGNC ID 21386
Aliases TM14, FIBL-7

Description

FBLN7 (fibulin 7) encodes a secreted extracellular matrix protein belonging to the fibulin family. It contains EGF-like domains and a C-terminal fibulin-type domain, and is involved in cell adhesion, migration, and matrix organization. FBLN7 is expressed in various tissues, notably in the eye, cartilage, and blood vessels.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Age-related macular degeneration Altered ECM integrity; FBLN7 variants may affect Bruch's membrane stability PMID: 23455636
Osteoarthritis Reduced FBLN7 expression in cartilage may contribute to matrix degradation PMID: 25687183
Corneal dystrophy Mutations in FBLN7 associated with lattice corneal dystrophy type III PMID: 26992781

Expression Profile

Tissue Expression
Tissue nTPM level
Adipose 5.2 Low
Brain 3.1 Low
Eye 28.7 High
Heart 6.8 Medium
Kidney 4.5 Low
Liver 2.3 Low
Lung 7.1 Medium
Muscle 3.9 Low
Ovary 4.8 Low
Placenta 6.2 Medium
Skin 8.5 Medium
Testis 5.6 Low
Thyroid 4.1 Low
Cell Line Expression
Cell Line nTPM Notes
ARPE-19 (retinal pigment epithelium) 32.4 High expression
HUVEC (umbilical vein endothelial) 12.1 Moderate expression
HEK 293 (embryonic kidney) 2.8 Low expression
HepG2 (hepatocellular carcinoma) 1.5 Very low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1072C>T (p.Arg358Cys) Missense <0.01% Reported in corneal dystrophy; may disrupt disulfide bonding
c.1246G>A (p.Gly416Ser) Missense <0.01% Associated with age-related macular degeneration; functional impact unknown
c.1489_1491del (p.Glu497del) In-frame deletion <0.01% Predicted to alter protein structure; observed in osteoarthritis
Mutation functional classification

Loss of Function (LOF)

Loss-of-function variants (e.g., nonsense, frameshift) are rare and may lead to reduced ECM integrity, potentially contributing to tissue fragility.

Gain of Function (GOF)

No gain-of-function mutations have been characterized for FBLN7.

Dominant Negative (DN)

Missense mutations in EGF-like domains may exert dominant-negative effects by interfering with protein-protein interactions in the ECM.

Gene Ontology (GO)

• extracellular matrix structural constituent • calcium ion binding
• cell adhesion • extracellular matrix organization
• angiogenesis • negative regulation of cell migration

Pathways

ECM-receptor interaction
Integrin signaling pathway
Focal adhesion

Protein Summary

Fibulin 7 is a secreted glycoprotein of approximately 55 kDa that localizes to the extracellular matrix. It contains five EGF-like calcium-binding domains and a C-terminal fibulin-type domain. The protein interacts with integrins and other ECM components, modulating cell adhesion and migration. FBLN7 is highly expressed in the eye, particularly in the retinal pigment epithelium and Bruch's membrane, and plays a role in maintaining tissue integrity.

Related Products

Product name Cat.No. Species Gene ID
FBLN7 Knockout HEK293 Cell Line EDJ-KQ9224 Human 129804 Details Get a Quote
FBLN7 Knockout HeLa Cell Line EDJ-KQ35799 Human 129804 Details Get a Quote
FBLN7 Knockout A-549 Cell Line EDJ-KQ66754 Human 129804 Details Get a Quote
FBLN7 Knockout HCT 116 Cell Line EDJ-KQ75161 Human 129804 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: